hip joint disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patients with an indication for primary THA as for an operative hip, and consented to the operation(both hips surgery possible). 2)Patients suitable for 32mm and 36mm demoral heads. 3)Patients aged from 20 to 75 years at the time of awritten consent, and the consent to participate in this clinical study is obtaioned before THA (Not gender specific).
Exclusion criteria
Exclusion criteria: 1)Patients whose weight is over 90kg, the weight restriction of the femoral components to be used. 2)Patients who are difficult to be followed for 5 years after THA(in cases that emergency treatments are expected during observation period such as patients recieving hemodialylsis and anticancer drug therapies, or patients will move) 3)Patients whose functions of the implanted device are difficult to evaluate due to of other organs such as heart and nervous system. 4)Patients who are evaluated to be unsuitable for subjects of this study by invetigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Linear wear of polyethylene liner | — |
Countries
Japan
Contacts
Niigata University Medical and Dental Hospital Division of Orthpaedic Surgery